Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Anebulo Pharmaceuticals, Inc. (ANEB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT"
09/28/2023 8-K Quarterly results
05/11/2023 8-K Quarterly results
Docs: "Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates"
03/08/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "MASTER SERVICES AGREEMENT This Master Services Agreement is made effective as of March 2, 2023 , by and between Anebulo Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business being 1415 Ranch Road 620 South, Suite 201, Lakeway, TX 78734 and Potrero Hill Advisors, LLC., a California limited liability corporation, with its principal place of business being 2010 El Camino Real #1311, Santa Clara, CA 95050 . The Company and Potrero are herein sometimes referred to individually as a “Party” and collectively as the “Parties.” WHEREAS, the Company wishes to engage Potrero to serve as an independent consultant for the purpose of providing the Company with certain strategic and financial advice and support services, as more fully described in Exhibit A attached hereto ;..."
02/10/2023 8-K Quarterly results
01/09/2023 8-K Investor presentation
Docs: "Anebulo Pharmaceuticals Announces Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid Intoxication"
10/28/2022 8-K Quarterly results
10/13/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "ARTICLE I"
09/29/2022 8-K Quarterly results
09/26/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
09/09/2022 8-K Quarterly results
Docs: "Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress"
07/05/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/01/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Anebulo Pharmaceuticals Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission"
02/11/2022 8-K Quarterly results
Docs: "Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2022 Financial Results and Recent Updates"
01/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT",
"Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director"
01/03/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication"
11/16/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
11/12/2021 8-K Quarterly results
Docs: "Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2022 Financial Results and Provides a Business Update"
09/22/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy